Cargando…
Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?
Heart disease remains a leading cause of mortality and a major worldwide healthcare burden. Recent advances in stem cell biology have made it feasible to derive large quantities of cardiomyocytes for disease modeling, drug development, and regenerative medicine. The discoveries of reprogramming and...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568945/ https://www.ncbi.nlm.nih.gov/pubmed/26183451 http://dx.doi.org/10.15252/emmm.201504395 |